Longeveron LGVN
NASDAQ LGVN
$2.59 -0.10 (-3.72%)
At close: Oct 1, 2026 · 4:00 PM EDT

Longeveron (LGVN) Total Debt (2021 - 2023)

Updated

Longeveron (LGVN) reported Total Debt of $586,000 for Q3 2023, up 1.4% from the prior quarter.

Analysis

Longeveron (LGVN) Total Debt (2021 - 2023) Analysis & Trends

At the end of FY2022, Longeveron posted Total Debt of $2.32 million, up 95.9% from FY2021.

  • By year, Total Debt came in at $1.18 million in FY2021.
  • Five-year quarterly Total Debt spans a low of $578,000 in Q2 2023 and a high of $2.32 million in Q4 2022.
  • Per Business Quant data, the three quarters before Q3 2023 came in at $578,000 (Q2 2023), $1.03 million (Q1 2023) and $2.32 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Longeveron 8.14 Mn -31.66 Mn 182,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 586,000.00
Jun 30, 2023 578,000.00
Mar 31, 2023 1.03 Mn
Dec 31, 2022 2.32 Mn
Dec 31, 2021 1.18 Mn
API Access

Longeveron Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=LGVN&period=max&api_key=YOUR_API_KEY